Precigen PGEN
NASDAQ PGEN
$7.11 -0.03 (-0.49%)
As of: Sep 4, 2026 · 3:59 PM EDT

Precigen (PGEN) Amortization of Deferred Charges (2018 - 2026)

Precigen (PGEN) posted quarterly Amortization of Deferred Charges of $345000.0 for Q1 2026, up 21.48% quarter-over-quarter from $284000.0 in Q4 2025.

Analysis

Precigen (PGEN) Amortization of Deferred Charges (2018 - 2026) Analysis & Trends

Precigen (PGEN) has reported Amortization of Deferred Charges for 8 consecutive years, with $345000.0 the latest figure, recorded in Q1 2026.

  • In Q1 2026, Amortization of Deferred Charges changed N/A year-over-year to $345000.0; the TTM figure through Mar 2026 stood at $629000.0 (changed N/A YoY), while the FY2025 annual figure was $356000.0, changed N/A from the prior year.
  • Amortization of Deferred Charges climbed to $345000.0 in Q1 2026 per PGEN's latest filing, from $284000.0 in the prior quarter.
  • Across five years, Amortization of Deferred Charges topped out at $345000.0 in Q1 2026 and bottomed at $26000.0 in Q2 2023.
  • Historically, Amortization of Deferred Charges has averaged $216375.0 across 4 years, with a median of $284000.0 in 2022.
  • Annual changes were most pronounced in 2022 — Amortization of Deferred Charges tumbled 96.51% — and 2023, when it slumped 88.03%.
  • Precigen's Amortization of Deferred Charges stood at $108000.0 in 2022, then sank by 75.93% to $26000.0 in 2023, then jumped by 992.31% to $284000.0 in 2025, then increased by 21.48% to $345000.0 in 2026.
  • Business Quant data shows PGEN's Amortization of Deferred Charges at $345000.0 in Q1 2026, $284000.0 in Q4 2025, and $26000.0 in Q2 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Precigen 2.53 Bn 2.53 Bn 52.17 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 361,000.00
Mar 31, 2026 345,000.00
Dec 31, 2025 284,000.00
Sep 30, 2025 72,000.00
Jun 30, 2023 26,000.00
Mar 31, 2023 34,000.00
Dec 31, 2022 108,000.00
Sep 30, 2022 338,000.00
Jun 30, 2022 312,000.00
Mar 31, 2022 284,000.00
Dec 31, 2021 3.09 Mn
Sep 30, 2021 3.01 Mn
Jun 30, 2021 2.88 Mn
Mar 31, 2021 2.75 Mn
Dec 31, 2020 2.78 Mn
Sep 30, 2020 2.71 Mn
Jun 30, 2020 2.58 Mn
Mar 31, 2020 2.52 Mn
Dec 31, 2019 2.50 Mn
Sep 30, 2019 2.43 Mn